TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
DMRA

Damora Therapeutics, Inc.

Healthcare · Biotechnology

20.80$ +0.4% vs. previous close Closing price · As of: Sep 28, 2026

Ownership

Ownership Structure

Who owns Damora Therapeutics, Inc. (DMRA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 67.1% of the shares are freely tradable; institutional investors hold 102.3%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 102.3%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 7.6%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 67.1%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 7.8%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 62Mio.

Largest Shareholders

Institutions

Institutions DMRA
Name Stake (%) Shares Change (%) Date
FMR Inc 14.65 9,045,481 +3,686.7 03/31/2026
Fairmount Funds Management LLC 14.11 8,713,000 +0.0 03/31/2026
venBio Select Advisor LLC 6.13 3,783,000 +0.0 03/31/2026
VR Adviser, LLC 5.84 3,603,595 +0.0 03/31/2026
FCPM III SERVICES BV 3.95 2,441,000 +0.0 03/31/2026
RA Capital Management, LLC 3.89 2,399,310 +0.0 03/31/2026
HHG PLC 3.83 2,362,696 +135,765.2 03/31/2026
Viking Global Investors LP 3.74 2,311,082 +0.0 03/31/2026
Bellevue Group AG 3.72 2,298,000 +0.0 03/31/2026
Remedium Capital Partners, LLC 3.31 2,045,473 +0.0 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?